These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12957843)

  • 1. Human lipoprotein (a)-induced reduction of platelet aggregation is not mediated by apolipoprotein A's lysine-binding regions.
    Barre D
    Front Biosci; 2003 Sep; 8():s1226-8. PubMed ID: 12957843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
    Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
    Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein (a) mediates the lipoprotein (a)-induced biphasic shift in human platelet cyclic AMP.
    Barre DE
    Thromb Res; 2003; 112(5-6):321-4. PubMed ID: 15041277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular nature and consequences of lipoprotein (a)'s association with platelets.
    Barre DE
    Protein Pept Lett; 2007; 14(9):839-42. PubMed ID: 18045222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
    Edelstein C; Mandala M; Pfaffinger D; Scanu AM
    Biochemistry; 1995 Dec; 34(50):16483-92. PubMed ID: 8845377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
    Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
    Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity.
    Xia J; May LF; Koschinsky ML
    J Lipid Res; 2000 Oct; 41(10):1578-84. PubMed ID: 11013299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
    Malle E; Ibovnik A; Leis HJ; Kostner GM; Verhallen PF; Sattler W
    Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):377-84. PubMed ID: 7749848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the effect of lysine analogues and salt on the conformation of lipoprotein(a).
    Fless GM; Halfman CJ; Kirk EW
    Biochemistry; 2000 Mar; 39(10):2740-7. PubMed ID: 10704226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a).
    Scanu AM; Pfaffinger D; Lee JC; Hinman J
    Biochim Biophys Acta; 1994 Oct; 1227(1-2):41-5. PubMed ID: 7918682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
    Barre DE
    Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
    Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
    J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoprotein (A) antagonises THE GPIIB/IIIA receptor on collagen and adp-stimulated human platelets.
    Barre DE
    Front Biosci; 2004 Jan; 9():404-10. PubMed ID: 14766377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
    Becker L; Cook PM; Koschinsky ML
    Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells.
    Liu JN; Kung W; Harpel PC; Gurewich V
    Biochemistry; 1998 Mar; 37(11):3949-54. PubMed ID: 9521716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of plasmin-induced platelet aggregation.
    Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus.
    Hughes SD; Lou XJ; Ighani S; Verstuyft J; Grainger DJ; Lawn RM; Rubin EM
    J Clin Invest; 1997 Sep; 100(6):1493-500. PubMed ID: 9294116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular accumulation of Lp(a): in vivo analysis of the role of lysine-binding sites using recombinant adenovirus.
    Hughes SD; Rubin EM
    Clin Genet; 1997 Nov; 52(5):361-6. PubMed ID: 9520127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein(a) binds to low-density lipoprotein at two distant sites in lipoprotein(a).
    Xu S
    Biochemistry; 1998 Jun; 37(26):9284-94. PubMed ID: 9649309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
    Chitayat S; Kanelis V; Koschinsky ML; Smith SP
    Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.